Publications
Information about journal articles, updated at 17-12-2023, from platform CIÊNCIAVITAE.
Extracellular Vesicle-Based Delivery of Silencing Sequences for the Treatment of Machado-Joseph Disease | Spinocerebellar Ataxia Type-3
David Rufino-Ramos; Kevin Leandro; Vitor Carmona; Inês Martins; Albuquerque, Patrícia R.; Ana Rita Fernandes; Henriques, Carina; et al, ASGCT 26th Annual Meeting. 16-05-2023.
Validation of the brain-targeting AAV- PHP.eB encoding cholesterol hydroxylase CYP46A1: a promising non-invasive therapeutic strategy for Spinocerebellar Ataxia Type 3
Serra, Beatriz; Duarte, Sónia; Françoise, PIGUET; Nathalie Cartier; Alves, Sandro; de Almeida, Luis Pereira; Perfeito, Rita, FENS Regional Meeting 2023. 03-05-2023.
Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3
Rufino-Ramos, David; Albuquerque, Patrícia R.; Leandro, Kevin; Carmona, Vitor; Martins, Inês M.; Fernandes, Rita; Henriques, Carina; et al, Molecular Therapy. 1275 - 1292. 5. 31. 2023. http://dx.doi.org/10.1016/j.ymthe.2023.04.001 . 10.1016/j.ymthe.2023.04.001 . Molecular Therapy
Restoring brain cholesterol turnover as a therapeutic strategy for Spinocerebellar Ataxia type-3: non-invasive delivery of the brain-targeting AAV-PHP.eB encoding the cholesterol hydroxylase CYP46A1
Beatriz Machado Serra; Sónia Duarte; Françoise, PIGUET; Sandro Alves; Nathalie Cartier; Luís Pereira de Almeida; Rita Perfeito, BEB Day 2023. 08-02-2023.
Systemic delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of Machado-Joseph disease: a promising therapeutic strategy
Beatriz Machado Serra; Duarte, Sónia; Nathalie Cartier; Sandro Alves; Pereira de Almeida, Luis ; Rita Perfeito, 01-12-2022.
Systemic delivery of the brain-targeting AAV-PHP.eB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of Machado-Joseph disease: a promising therapeutic strategy
Beatriz Machado Serra; Sónia P. Duarte; Nathalie Cartier; Sandro Alves; de Almeida, Luis Pereira; Rita Perfeito, 29th Meeting of the European Society for Gene and Cell Therapy (ESGCT). 12-10-2022.
Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease (MJD) / Spinocerebellar Ataxia Type 3 (SCA3)
D. Rufino-Ramos; Kevin Leandro; Patrícia Albuquerque; Vitor Carmona; Maria Inês Martins; Faro, Rosario; Carina Henriques; et al, 29th Meeting of the European Society for Gene and Cell Therapy (ESGCT). 13-10-2022.
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
Walter, Jonas; Bolognin, Silvia; Poovathingal, Suresh K.; Magni, Stefano; Gérard, Deborah; Antony, Paul M.A.; Nickels, Sarah L.; et al, Cell Reports. 3. 37. 2021. http://dx.doi.org/10.1016/j.celrep.2021.109864 . 10.1016/j.celrep.2021.109864 . published Cell Reports
Vale a pena financiar a investigação em doenças raras? - Conteúdo Multimédia "A Saúde no Saber"
Carolina Simões; Rita Perfeito; Sónia Duarte; João Cardoso; Luís Pereira de Almeida, 07-2021.
Intranasal delivery of extracellular vesicles carrying silencing sequences alleviates Machado-Joseph Disease
Rufino-Ramos, David; Kevin Leandro; Vitor Carmona; Inês M. Martins; Manuela Paolleta; Patrícia R. Albuquerque; Rosário Faro; et al, XVII Meeting of the Portuguese Society for Neuroscience. 01-12-2021.
Terapia génica: uma chave para o tratamento de doenças raras?
Luís Pereira de Almeida; André Caetano; Rita Perfeito; João Cardoso; Correia, Marta Quatorze; Sara Varela Amaral, Jornal Público. 21-07-2021. Jornal Público
Intravenous delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of spinocerebellar ataxia type 3: a promising non-invasive therapeutic strategy
Serra, Beatriz; Sónia P. Duarte; Nathalie Cartier; Sandro Alves; de Almeida, Luis Pereira; Rita Perfeito, XVII Meeting of the Portuguese Society for Neuroscience. 02-12-2021.
Uma Viagem Rara
Ana Catarina Vinhas; Ana Cristina Ferreira; Carina Henriques; Carolina Silva; Catarina Oliveira Miranda; Daniel Henriques; Daniela Oliveira; et al, PÚBLICO. 28-02-2020. PÚBLICO
Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality
Walter, Jonas; Bolognin, Silvia; Antony, Paul M.A.; Nickels, Sarah L.; Poovathingal, Suresh K.; Salamanca, Luis; Magni, Stefano; et al, Stem Cell Reports. 878 - 889. 5. 12. 2019. http://dx.doi.org/10.1016/j.stemcr.2019.03.004 . 10.1016/j.stemcr.2019.03.004 . published Stem Cell Reports
Intersection of exosome secretion and autophagy on alpha-synuclein spreading profile in Parkinson's disease cell models
Perfeito, Rita; Anjos, Vanessa; Marques, Andreia; Nobre, Rui; Garrido, Manuel; Schwamborn, Jens; De Almeida, Luís, Frontiers in Cellular Neuroscience. 13. 2019. http://dx.doi.org/10.3389/conf.fncel.2019.01.00015 . 10.3389/conf.fncel.2019.01.00015 . published Frontiers in Cellular Neuroscience
Intersection of autophagy and exosome secretion on alpha-synuclein spreading pattern in in vitro models of Parkinson's disease
Perfeito, Rita; Vanessa Anjos; Rui Jorge Nobre; Manuel Garrido; Jens C. Schwamborn; Luís Pereira de Almeida, 15-05-2019.
Extracellular Vesicles for therapy of spinocerebellar ataxia type 3
David Rufino-Ramos; Vitor Carmona; Inês M. Martins; M. Barreira; Patrícia R. Albuquerque; Rosário Faro; Perfeito, Rita; Rui Jorge Nobre; Luís Pereira de Almeida, 10-12-2019.
Roles and Mechanisms of alpha-synuclein and ataxin-3 spreading in Parkinson and Machado Joseph diseases - SynSpread
Perfeito, Rita; Ohein, M; Jens C. Schwamborn; Fleming, R; Luís Pereira de Almeida, JPND/JPco-funND Conference (Brussels - Belgium). 27-11-2019.
Intercellular transport of alpha-synuclein in the context of Parkinson's disease
Andreia Marques; David Rufino-Ramos; Carina Henriques; Jens C. Schwamborn; Perfeito, Rita; Luís Pereira de Almeida, 1st Annual Meeting in Pharma (Coimbra, Portugal). 15-11-2019.
Intersection of autophagy and exosome secretion on alpha-synuclein spreading profile in Parkinson's disease cell models
Rita Perfeito; Vanessa Anjos; Andreia Marques; Rui Jorge Nobre; Manuel Garrido; Jens C. Schwamborn; Luís Pereira de Almeida, XVI Meeting of the Portuguese Society for Neuroscience (Lisboa, Portugal). 30-05-2019.
EVs as natural carriers of miRNAs against Machado-Joseph disease
D. Rufino-Ramos; V. Carmona; P. R. Albuquerque; Rita Perfeito; R. J. Nobre; T. M. Ribeiro-Rodrigues; H. Girão, 1st Meeting on Vesicular Biology (Coimbra, Portugal). 16-02-2018.
Optimization of a size-exclusion chromatograhy protocol to isolate plasma-derived extracellular vesicles
Laetitia Gaspar; Magda Santana; Perfeito, Rita; Patrícia Albuquerque; Teresa M. Ribeiro Rodrigues; Henrique Girão; Rui Jorge Nobre; Luís Pereira de Almeida, Journal of Extracellular Vesicles. sup1. 7. 2018. http://dx.doi.org/10.1080/20013078.2018.1461450 . 10.1080/20013078.2018.1461450 . published Journal of Extracellular Vesicles
Optimization of a size exclusion chromatography protocol to isolate plasma-derived extracellular vesicles for transcriptional biomarkers research
L. Gaspar; M. Santana; Rita Perfeito; P. Albuquerque; T. M. Ribeiro-Rodrigues; H. Girão; R. J. Nobre; L. P. de Almeida, ISEV Annual Meeting (Barceloma, Spain). 02-05-2018.
Optimization of a size exclusion chromatography protocol to isolate plasma-derived extracellular vesicles for transcriptional analysis
M. Santana; L. Gaspar; Rita Perfeito; P. Albuquerque; T. M. Ribeiro-Rodrigues; H. Girão; R. J. Nobre; L. P. de Almeida, 1st Meeting on Vesicular Biology (Coimbra, Portugal). 16-02-2018.
Novel promising vesicles carrying artificial miRNAs against Machado-Joseph disease
David Rufino-Ramos; Vitor Carmona; Patrícia R. Albuquerque; Rita Perfeito; Rui J. Nobre; Luís P. de Almeida, XII Spanish-Portuguese Conference on Controlled Drug Delivery (Coimbra, Portugal). 14-01-2018.
Stem Cell-Based Therapies for Polyglutamine Diseases
Mendonça, L.S.; Onofre, I.; Miranda, C.O.; Perfeito, R.; Nóbrega, C.; de Almeida, L.P., Protein misfolding in Biology and Disease. Luís Pereira de Almeida; Clévio Nóbrega. Springer. 2018. published
Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells
Perfeito, R.; Ribeiro, M.; Rego, A.C., Archives of Toxicology. 1245 - 1259. 3. 91. 2017. http://www.scopus.com/inward/record.url?eid=2-s2.0-84978795483&partnerID=MN8TOARS . 10.1007/s00204-016-1788-6 . published Archives of Toxicology
Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases
Rufino-Ramos, D.; Albuquerque, P.R.; Carmona, V.; Perfeito, R.; Nobre, R.J.; Pereira de Almeida, L., Journal of Controlled Release. 247 - 258. 262. 2017. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026758579&partnerID=MN8TOARS . 10.1016/j.jconrel.2017.07.001 . published Journal of Controlled Release
Alpha-synuclein secretion in in vitro models of Parkinson's disease - a role for autophagy
Rita Perfeito; Vanessa Anjos; Rui J. Nobre; Manuel Garrido; Luís P. de Almeida, XV Meeting of the Portuguese Society for Neuroscience (Braga, Portugal). 25-05-2017.
Extracellular vesicles as emergent natural carriers of small nucleic acids
David Rufino-Ramos; Vitor Carmona; Patrícia Albuquerque; Rita Perfeito; Rui J. Nobre; Luís P. de Almeida, MicroBiotec (Porto, Portugal). 07-12-2017.
Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing a-Synuclein
Noronha, C.; Perfeito, R.; Laço, M.; Wüllner, U.; Rego, A.C., Neurochemical Research. 1430 - 1437. 5. 42. 2017. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013849882&partnerID=MN8TOARS . 10.1007/s11064-017-2199-7 . published Neurochemical Research
Autophagy activation prevents alpha-synuclein secretion in exosomes
Perfeito, Rita; Vanessa Anjos; Rui Jorge Nobre; Manuel Garrido; Luís Pereira de Almeida, Journal of Extracellular Vesicles. 1. 5. 2016. http://dx.doi.org/10.3402/jev.v5.31552 . 10.3402/jev.v5.31552 . published Journal of Extracellular Vesicles
Autophagy activation prevents alpha-synuclein secretion in exosomes
Rita Perfeito, Annual Meeting - ISEV (Rotterdam, The Netherlands). 04-05-2016.
Alpha-synuclein is transported and induces neuropathological and motor behaviour abnormalities upon overexpression in the rat striatum
Rita Perfeito, XIV Meeting of the Portuguese Society for Neuroscience (Póvoa do Varzim, Portugal). 04-06-2015.
Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells
Perfeito, R.; Lázaro, D.F.; Outeiro, T.F.; Rego, A.C., Molecular and Cellular Neuroscience. 51 - 59. 62. 2014. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906751686&partnerID=MN8TOARS . 10.1016/j.mcn.2014.08.002 . published Molecular and Cellular Neuroscience
Generation of a genetic model of Parkinson's disease based on alpha-synuclein overexpression in the striatum
Rita Perfeito, XII Annual CNC Meeting. 15-12-2014.
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease - Resemblance to the effect of amphetamine drugs of abuse
Perfeito, R.; Cunha-Oliveira, T.; Rego, A.C., Free Radical Biology and Medicine. 186 - 201. 62. 2013. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884889978&partnerID=MN8TOARS . 10.1016/j.freeradbiomed.2013.05.042 . published Free Radical Biology and Medicine
Overexpression of wild-type alpha-synuclein increases susceptibility to oxidative stress in SH-SY5Y cells
Rita Perfeito, International Symposium on Redox Signaling and Oxidative stress in Health and Disease (Valencia, Spain). 05-06-2012.
Interplay between oxidative stress and alpha-synuclein phosphorylation in Parkinson's disease cell models
Rita Perfeito, Society for Neuroscience (New Orleans, USA). 13-10-2012.
Interplay between alpha-synuclein and oxidative stress in Parkinson's disease cell models
Perfeito, Rita, phd. Universidade de Coimbra . 28-12-2012.
Oxidative stress in SH-SY5Y cells conditionally overexpressing wild-type alpha-synuclein
Rita Perfeito, 8th FENS Forum of European Neuroscience (Barcelona, Spain). 14-07-2012.
Effects of alpha-synuclein overexpression in cellular response to oxidative stress - insights for Parkinson's disease
Rita Perfeito, 26ª reunião do GEECD (Tomar, Portugal). 29-06-2012.
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease - Resemblance to the effect of amphetamine drugs of abuse
Perfeito, R.; Cunha-Oliveira, T.; Rego, A.C., Free Radical Biology and Medicine. 1791 - 1806. 9. 53. 2012. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867397192&partnerID=MN8TOARS . 10.1016/j.freeradbiomed.2012.08.569 . published Free Radical Biology and Medicine
Role of alpha-synuclein and Parkinson's disease-associated mitochondrial dysfunction,Papel da alfa-sinucleína e da disfunção mitocondrial associada à doença de Parkinson
Perfeito, R.; Rego Prof., A.C., Revista Neurociencias. 273 - 284. 2. 20. 2012. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863884807&partnerID=MN8TOARS . published Revista Neurociencias
Wild-type alpha-synuclein overexpression modifies nuclear and mitochondrial transcription factors
Rita Perfeito, 5th Annual Meeting of Cell Signaling (Coimbra, Portugal). 28-04-2011.
Alpha-synuclein phosphorylation at Serine 129 is induced by oxidative stress and influences its secretion in a Parkinson's disease cellular model
Rita Perfeito, The 10th International Conference on Alzheimer's and Parkinson's disease (ADPD) (Barcelona, Spain). 09-03-2011.
Linking alpha-synuclein phosphorylation at Ser129 to reactive oxygen species formation in SH-SY5Y cells
Perfeito, Rita; Catarina Resende de Oliveira; Ana Cristina Carvalho Rego, 2010.
Iron-Induced Oxidative Stress and Rotenone Modify Alpha-synuclein Phosphorylation in a Cellular Model of Parkinson's Disease
Rita Perfeito; Catarina Resende de Oliveira; Ana Cristina Carvalho Rego, Frontiers in Neuroscience. 3. 2009. http://dx.doi.org/10.3389/conf.neuro.01.2009.11.061 . 10.3389/conf.neuro.01.2009.11.061 . published Frontiers in Neuroscience
Iron-induced oxidative stress and rotenone modify alpha-synuclein phosphorylation in a cellular model of Parkinson's disease
Rita Perfeito, 11th Meeting of the Portuguese Society for Neuroscience (Braga, Portugal). 04-06-2009.
Alpha-synuclein phosphorylation mediated by iron and rotenone in a cellular model of Parkinson's disease
Perfeito, R.; Oliveira, C.; Rego, A.C., Parkinsonism & Related Disorders. P3.011. 15. 2009. http://dx.doi.org/10.1016/s1353-8020(09)70575-9 . 10.1016/s1353-8020(09)70575-9 . published Parkinsonism & Related Disorders
Post-translational modifications of alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
Perfeito, Rita; Doutora Ana Cristina Carvalho Rego, Protein misfolding in Biology and Disease. Tiago Flemming Outeiro. Transworld Research Network. 2008.
Influence of iron and rotenone on alpha-synuclein post-translational modifications in cellular models of Parkinson's disease
Rita Perfeito, 6th FENS Forum of European Neuroscience (Geneve - Switzerland). 12-07-2008.
Mitochondrial dysfunction and Cell Toxicity in Parkinson's disease models
Rita Perfeito, 10th Meeting of the Portuguese Society for Neuroscience (Ofir - Portugal). 23-05-2007.
Trolox protection of myelin membrane in hydrogen peroxide-treated mature oligodendrocytes
Perfeito, R.; Pereira, J.; Oliveira, C.; Bettencourt-Relvas, J.; Rego, A.C., Free Radical Research. 444 - 451. 4. 41. 2007. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947493269&partnerID=MN8TOARS . 10.1080/10715760601134442 . published Free Radical Research
Protection from oxidative lesion in rat oligodendrocytes
Perfeito, Rita, degree. Universidade de Coimbra Faculdade de Ciencias e Tecnologia . 2005.
5 55 out of 55 Publications
All projects
Information of exclusive responsibility of the researcher 17-12-2023 , from platform CIÊNCIAVITAE.
2023/09/01 -
CinTech - Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs
12345
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB)
2023/03/01 - 2024/08/31
Pre-clinical evaluation of the brain-targeting AAV-PHP.eB encoding cholesterol hydroxylase CYP46A1 as a therapeutic strategy for spinocerebellar ataxia type 3 - towards the understanding of the neuroprotective mechanism
2022.04788.PTDC
Principal investigator
Centro de Inovação em Biomedicina e Biotecnologia (CIBB); Universidade de Coimbra
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2023/01/01 - 2024/06/30
Conversão Directa de Astrócitos em Neurónios Cerebelares como tratamento Inovador para a Ataxia Espinocerebelosa do Tipo-3
2022.06127.PTDC
Researcher
Centro de Inovação em Biomedicina e Biotecnologia (CIBB); Universidade de Coimbra
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2021/01/01 - 2025/12/31
Centro de Inovação em Biomedicina e Biotecnologia - Laboratório Associado
LA/P/0058/2020
Researcher
CNC.IBILI
2020/01/01 - 2023/12/31
Centro de Inovação em Biomedicina e Biotecnologia
UIDB/04539/2020
Researcher
CNC.IBILI
2020/08/01 - 2020/10/31
Verão com Ciência: Metodologias de Investigação Científica - I&D: Terapia Génica e Células Estaminais
MIC IIIUC
Researcher
Universidade de Coimbra; Universidade de Coimbra Instituto de Investigação Interdisciplinar
Funders: Fundação para a Ciência e a Tecnologia
2020/03 - 2022/12
Intravenous delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of spinocerebellar ataxia type 3: a promising non-invasive therapeutic strategy
686213
Principal investigator
2019/01 - 2022/12/31
Gene Therapy for Cerebellar Ataxias: restoring cholesterol metabolism by targeting brain cholesterol 24 hydroxylase (CYP46A1) - SCA-CYP (E-RARE International Consortium)
E-Rare-3 JTC 2017
Researcher
CNC.IBILI
2018/06 - 2022/06/14
The impact of induced pluripotent stem cells-derived neuroepithelial stem cells transplantation in Machado-Joseph disease
PTDC/BTM-ORG/30737/2017
Researcher
CNC.IBILI
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2018/07 - 2021/06
Role of microRNA deregulation in Machado-Joseph disease: on the development of a microRNA-based therapeutic strategy
PTDC/MED-NEU/32309/2017
Researcher
CNC.IBILI
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2017/01 - 2020/12
Brain Health 2020
CENTRO-01-0145-FEDER-000008
Researcher
CNC.IBILI
2016/05 - 2019/04
Control of cardiomyocyte proliferation in disease and regenerative medicine
PTDC/BIM-MED/3363/2014
Researcher
CNC.IBILI
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2016/01 - 2016/12
Does the transplantation of mutant ataxin-3-depleted patient-derived NSC alleviates Machado Joseph disease (MJD)?
20126
Researcher
CNC.IBILI
Funders: AFM-Téléthon
2015/01 - 2018/12
CNC.IBILI
UID/NEU/04539/2013
Researcher
CNC.IBILI
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2015/01 - 2015/12
The transplantation of induced pluripotent stem cells (iPSC)-derived neural stem cells (NSC) in Machado-Joseph disease (MJD)
Research Seed Money Award
Researcher
Centro de Neurociências e Biologia Celular
Funders: National Ataxia Foundation
2015/03/01 - 2018/12
Roles and mechanisms of synuclein and ataxin-3 spreading in Parkinson and Machado-Joseph diseases - SynSpread (JPND - International Consortium)
JPND SynSpread: CD/0001/2013
Researcher
Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia
2015/07/01 - 2019/01/31
Role and mechanisms of alpha-synuclein spreading in Parkinson's disease
SFRH/BPD/100130/2014
Post-doc Fellow
Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia, I.P.
2014/09/01 - 2015/06/30
New strategies to manage brain diseases
CENTRO-07-ST24FEDER-002002
Post-doc Fellow
Centro de Neurociências e Biologia Celular; Universidade de Coimbra
Funders: Universidade de Coimbra
2014/06/01 - 2014/08/31
Cell to cell transport of alpha-synuclein in Parkinson's disease. The progression factor?
PTDC/SAU-NMC/109955/2009
Post-doc Fellow
Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia
2011/10 - 2012/07
Alpha-synuclein modifications in peripheral blood lymphocytes from sporadic and familial Parkinson's disease patients
PDCR02
Researcher
Centro de Neurociências e Biologia Celular
Funders: Faculdade de Medicina, Universidade de Coimbra
2010/06/01 - 2013/01/31
Deciphering the molecular mechanisms linking alpha-synuclein dysfunction and cytotoxicity in Parkinson's disease - the role of GDNF
Provided by PTCRIS: 101928
Research Technician Fellow
Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia
2006/06/01 - 2010/05/31
Interplay between alpha-synuclein and oxidative stress in Parkinson's disease cell models
SFRH/BD/25515/2005
PhD Student Fellow
Universidade de Coimbra; Centro de Neurociências e Biologia Celular
Funders: Fundação para a Ciência e a Tecnologia, I.P.
5 22 out of 22 projects
We use cookies to improve your visit to our website.
